ArticleHead & neck2025

Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up.

Pauline Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.